We are pleased to officially announce the launch of our new website, which reflects our expanding role as a leading professional service provider to pharmaceutical, biotechnology and medical device companies.
We are highlighting our services for Advanced Therapeutic Medicinal Products (ATMPs – which include cell and gene therapies). As our business continues to expand, the goal with this new website is to provide clear visibility on our services and the cross-functional experts we have at HiTech Health to support your company’s needs. The website now details the wide range of capabilities we offer surrounding cell and gene therapy services and at our process development laboratory in Galway, Ireland. This state-of-the-art facility is open for business and we can perform activities ranging from process and analytical development to personalised training in the lab.
Visitors can explore the many services we offer to a diverse range of clients ranging from early stage pre-clinical companies to large multinational corporations. Our focus is on Operations (CMC) from early product development through to product launch, HiTech Health has the experts that can enable a successful product registration and launch. Our team have led the development, manufacture, and supply of multiple products including cell and gene therapies to patients in several countries. We provide quality and compliance, QP and regulatory expertise, our team can be an extension of your internal resources. You can read about these services and much more on the new website. Going forward, we will continue to communicate regularly on the latest industry news and insights, as well as upcoming events where you can meet some of our team.
Recent News
Breakthrough Gene Therapy Becomes First to Slow Progression of Huntington’s Disease
UK researchers said on Wednesday they have slowed the progression of the fatal neural condition Huntington's disease for the first time with a groundbreaking new gene therapy. Huntington's disease causes nerve cells in the brain to decay over time. The disease affects...
Wholesale Distribution Authorisation (WDA): What is a WDA and why is it important?
Pharmaceutical and biotechnology companies are required to comply with strict regulations to ensure medicines are safe and effective. One key requirement for wholesaling activities is the Wholesale Distribution Authorisation (WDA). In the EU and UK, all wholesale...
ATMP Sector Spotlight: H1 2025 Review
The HiTech Health team has reviewed recent developments in the Advanced Therapeutic Medicinal Product (ATMP) sector during the first half of 2025. Below are some key updates from the industry so far: Sector Summary: In Europe, the ATMP sector is on track to...
Stay Up To Date
Connect with us to receive the latest HiTech Health and industry updates.